Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyMaarten J. Titulaer, Josep Dalmau, Lawrence S. Honig et al.|The Lancet Neurology|2013Cited by 3.1k
Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective studyNúria Gresa‐Arribas, Josep Dalmau, Maarten J. Titulaer et al.|The Lancet Neurology|2013Cited by 1.3k
Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodiesMar Petit‐Pedrol, Josep Dalmau, Thaís Armangué et al.|The Lancet Neurology|2014Cited by 615